Summary

Viral vectors, pseudoviruses, antiviral discovery, antibody discovery, gene therapy, viral diagnostics, public health, biodefense, Alpha-pseudoviruses, AAV encapsulation, Infectin™ technology, neutralization assays, virus manufacturing, BSL2 virus production, viral assays, viral standards, VLPs, virus recovery, custom viral vectors, reporter viruses, hybridoma generation, cell line engineering, CRISPR-Cas9, gene knockouts

Description

Virongy Biosciences Inc. is a biotechnology company dedicated to advancing viral vector technologies, diagnostic tools, and the discovery of antivirals and antibodies for viral pathogens critical to public health and biodefense. Our patented platforms, including Alpha-pseudoviruses, advanced AAV encapsulation, and Infectin™ technologies, enable rapid quantification of antivirals and neutralizing antibodies, as well as enhanced gene therapy delivery. Committed to continuous innovation and backed by decades of virology expertise, we empower clients to accelerate discoveries and address emerging viral threats.

Profile

  • Incorporated in
    Virginia
  • Established since
    2021
  • Main/Branch
    Branch

Address

Contact